Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1593

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (Description)

This is a concentration table for lidocaine hydrochloride (anhydrous) and sodium chloride in milligrams per milliliter. The concentration is represented in three different percentages: 1%, 10 mg/mL lidocaine HCL (anhyd.), 15 mg/mL lidocaine HCL (anhyd.), 20 mg/mL lidocaine HCL (anhyd.). Additionally, the table shows the concentration of sodium chloride which is 7 mg/mL for the 1% lidocaine HCL (anhyd.) concentration, 65 mg/mL for the 10 mg/mL lidocaine HCL (anhyd.) concentration and 6 mg/mL for the 20 mg/mL lidocaine HCL (anhyd.) concentration.*

FDA Label Image

D1 (Dosage 1)

This is a description of various concentrations and packaging options for a medical product. The product comes in different concentrations of 1%, 1.5%, and 2%. The packaging options include single-dose tear-top vials with a volume of 30 mL, and single-dose ampuls with volumes of 20 mL and 10 mL.*

FDA Label Image

D2 (Dosage 2)

This is a table outlining the recommended dosages for Lidocaine Hydrochloride Injection, USP for various types of nerve blocks and anesthesias. The table provides the recommended concentration percentage, volume, and total dosage of Lidocaine Hydrochloride Injection, USP for each respective type. The dosages are determined by the number of dermatomes to be anesthetized.*

FDA Label Image

L2 (Logo 2)

FDA Label Image

Logo (Logo)

FDA Label Image

Case Labeling (Lidocaine Case Label)

Lidocaine HC L Injection is a prescription medication that contains a 1% solution of lidocaine hydrochloride. Each 2ml ampule contains 18mg/ml of lidocaine hydrochloride, and is sold in a case of 50. This medication is for injection use only and should only be administered by a healthcare professional. The provided text does not contain readable information beyond the drug name and specifications.*

FDA Label Image

Pouch Labeling (Pouch 2)

Lidocaine HCl Injection is a prescription drug with a strength of 1%, containing 20mg/2mL (18ng/mL). The product is packaged in a 2mL ampoule and is for intravenous use only. The drug is marked as RXONLY.*

FDA Label Image

Precautions (Precautions)

This text provides a list of drugs that have been associated with Methemoglobinemia, a condition in which blood is unable to carry oxygen efficiently. The list includes different types of drugs such as nitrates, local anesthetics, antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs like acetaminophen, metoclopramide, quinine, and sulfasalazine. Methemoglobinemia is a rare but serious side effect of these drugs, and proper monitoring is necessary to detect and treat the condition in a timely manner.*

FDA Label Image

Rfid Labeling (Rfid 1)

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial 2)

This seems to be the text obtained by scanning an image or document. It includes some random characters and incomplete phrases, making it difficult to provide a specific description. Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.